The overall treatment plan for cerebral infarction is to control underlying diseases, promote blood circulation, and protect brain cells.

Specifically, within the ultra-early stage (within 4.5 hours of onset), intravenous thrombolysis with rt-PA can be considered.

Other treatments include antiplatelet aggregation, defibrination, and anticoagulation therapy. The main drugs used are aspirin, clopidogrel, batroxobin, argatroban, etc.

On this basis, statin drugs should be used for anti-atherosclerosis treatment, along with comprehensive treatments such as protecting brain cells and reducing oxygen free radical damage.